Skip to main content

Table 2 Serotype counts across carriage, non-IPD and IPD studies

From: Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysis

Country

Serotype

Carriage

Non-IPD

IPD

Total

Number of isolates per serotype N (%)

≤5 N (%)

> 5 N (%)

Unreported N (%)

≤5 N (%)

> 5 N (%)

Unreported N (%)

≤5 N (%)

> 5 N (%)

Unreported N (%)

 

PCV10

Malaysia

1

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (1.7)

22 (6.3)

6 (1.8)

14 (4.4)

33 (9.4)

78 (3.8)

4

0 (0.0)

1 (3.3)

0 (0.0)

0 (0.0)

4 (2.2)

1 (0.3)

2 (0.6)

9 (2.8)

5 (1.42)

22 (1.1)

5

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

4 (2.2)

0 (0.0)

1 (0.3)

3 (0.9)

7 (2.0)

15 (0.7)

6B

8 (6.1)

4 (13.3)

5 (2.6)

12 (8.1)

10 (5.6)

16 (4.6)

60 (17.8)

24 (7.5)

24 (6.8)

163 (8.0)

7F

0 (0.0)

0 (0.0)

0 (0.0)

1 (0.7)

0 (0.0)

1 (0.3)

2 (0.6)

7 (2.2)

3 (0.9)

14 (0.7)

9 V

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (0.3)

3 (0.9)

2 (0.6)

6 (0.3)

14

1 (0.8)

2 (6.7)

1 (0.5)

6 (4.0)

6 (3.4)

8 (2.3)

74 (21.9)

30 (9.4)

38 (10.8)

166 (8.1)

18C

2 (1.5)

0 (0.0)

0 (0.0)

2 (1.3)

6 (3.4)

4 (1.1)

11 (3.3)

7 (2.2)

12 (3.4)

44 (2.2)

19F

6 (4.6)

2 (6.7)

46 (23.5)

27 (18.1)

34 (19.1)

84 (24.1)

27 (8.0)

42 (13.2)

45 (12.8)

313 (15.3)

23F

13 (9.9)

2 (6.7)

26 (13.3)

15 (10.1)

8 (4.5)

29 (8.3)

20 (5.9)

24 (7.5)

29 (8.2)

166 (8.1)

PCV13

3

1 (0.8)

1 (3.3)

2 (1.0)

1 (0.7)

6 (3.4)

12 (3.4)

4 (1.2)

17 (5.3)

9 (2.6)

53 (2.6)

6A

21 (16.0)

1 (3.3)

13 (6.6)

21 (14.1)

6 (3.4)

2 (0.6)

36 (10.7)

17 (5.3)

16 (4.5)

133 (6.5)

19A

8 (6.1)

0 (0.0)

14 (7.1)

10 (6.7)

4 (2.2)

7 (2.0)

38 (11.2)

31 (9.7)

26 (7.4)

138 (6.8)

PCV15

22F

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

3 (0.9)

0 (0.0)

1 (0.3)

0 (0.0)

4 (0.2)

33F

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

PCV20

8

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (0.3)

0 (0.0)

1 (0.3)

2 (0.1)

10A

0 (0.0)

0 (0.0)

0 (0.0)

2 (1.3)

0 (0.0)

4 (1.1)

0 (0.0)

0 (0.0)

1 (0.3)

7 (0.3)

11A

3 (2.3)

1 (3.3)

0 (0.0)

3 (2.0)

0 (0.0)

3 (0.9)

3 (0.9)

2 (0.6)

0 (0.0)

15 (0.7)

12F

0 (0.0)

0 (0.0)

1 (0.5)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

1 (0.05)

15B

0 (0.0)

0 (0.0)

0 (0.0)

5 (3.6)

0 (0.0)

2 (0.6)

1 (0.3)

0 (0.0)

0 (0.0)

8 (0.4)

VRT

51 (38.9)

7 (23.3)

46 (23.5)

7 (4.7)

1 (0.6)

75 (21.6)

17 (5.0)

13 (4.1)

48 (13.6)

265 (13.0)

NVT

1 (0.8)

3 (10.0)

9 (4.6)

16 (10.7)

8 (4.5)

30 (8.6)

1 (0.3)

12 (3.8)

29 (8.2)

109 (5.3)

NT

2 (1.5)

6 (20.0)

33 (16.8)

2 (1.3)

21 (11.8)

21 (6.0)

16 (4.7)

11 (3.5)

16 (4.5)

128 (6.3)

Unknown

14 (10.7)

0 (0.0)

0 (0.0)

19 (12.8)

57 (32.0)

24 (6.9)

17 (5.0)

51 (16.0)

8 (2.3)

190 (9.3)

Total

131 (100)

30 (100)

196 (100)

149 (100)

178 (100)

348 (100)

338 (100)

318 (100)

352 (100)

2040 (100)

  1. VRT Vaccine Related, Types NVT Non-Vaccine Types, NY Non-Typeable, PCV Pneumococcal Conjugate Vaccine. IPD Invasive Pneumococcal Disease. Non-IPD Non-Invasive Pneumococcal Disease